False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake

被引：7

作者：

Hartrampf, Philipp E. ^{[1
]}

Seitz, Anna Katharina ^{[2
]}

Krebs, Markus ^{[2
,3
]}

Buck, Andreas K. ^{[1
]}

Lapa, Constantin ^{[1
,4
]}

机构：

[1] Univ Hosp Wurzburg, Dept Nucl Med, Wurzburg, Germany

[2] Univ Hosp Wurzburg, Dept Urol & Paediat Urol, Wurzburg, Germany

[3] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany

[4] Univ Hosp Augsburg, Dept Nucl Med, Augsburg, Germany

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / 08期

关键词：

Liver; -; Urology;

D O I：

10.1007/s00259-019-04645-5

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

[No abstract available]

引用

页码：2044 / 2046

页数：3

共 5 条

[1] F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients [J].

Giesel, Frederik L. ;

Hadaschik, B. ;

Cardinale, J. ;

Radtke, J. ;

Vinsensia, M. ;

Lehnert, W. ;

Kesch, C. ;

Tolstov, Y. ;

Singer, S. ;

Grabe, N. ;

Duensing, S. ;

Schaefer, M. ;

Neels, O. C. ;

Mier, W. ;

Haberkorn, U. ;

Kopka, K. ;

Kratochwil, C. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (04) :678-688

[2] [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study [J].

Hofman, Michael S. ;

Violet, John ;

Hicks, Rodney J. ;

Ferdinandus, Justin ;

Thang, Sue Ping ;

Akhurst, Tim ;

Iravani, Amir ;

Kong, Grace ;

Kumar, Aravind Ravi ;

Murphy, Declan G. ;

Eu, Peter ;

Jackson, Price ;

Scalzo, Mark ;

Williams, Scott G. ;

Sandhu, Shahneen .

LANCET ONCOLOGY, 2018, 19 (06) :825-833

[3] Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving 177Lu-PSMA-617 [J].

Kessel, Katharina ;

Seifert, Robert ;

Schaefers, Michael ;

Weckesser, Matthias ;

Schlack, Katrin ;

Boegemann, Martin ;

Rahbar, Kambiz .

THERANOSTICS, 2019, 9 (17) :4841-4848

[4]

Kratochwil C, 2019, EUR J NUCL MED MOL I

[5]

Thang SP., 2018, Eur Urol Oncol

← 1 →